KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Receivables - Other (2017 - 2025)

Historic Receivables - Other for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $81.0 million.

  • Elanco Animal Health's Receivables - Other rose 2656.25% to $81.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.0 million, marking a year-over-year increase of 2656.25%. This contributed to the annual value of $81.0 million for FY2024, which is 5178.57% down from last year.
  • Latest data reveals that Elanco Animal Health reported Receivables - Other of $81.0 million as of Q3 2025, which was up 2656.25% from $114.0 million recorded in Q2 2025.
  • Elanco Animal Health's Receivables - Other's 5-year high stood at $225.0 million during Q2 2023, with a 5-year trough of $64.0 million in Q3 2024.
  • For the 5-year period, Elanco Animal Health's Receivables - Other averaged around $150.3 million, with its median value being $158.0 million (2021).
  • Per our database at Business Quant, Elanco Animal Health's Receivables - Other soared by 12316.38% in 2021 and then tumbled by 7142.86% in 2024.
  • Over the past 5 years, Elanco Animal Health's Receivables - Other (Quarter) stood at $195.0 million in 2021, then increased by 5.13% to $205.0 million in 2022, then dropped by 18.05% to $168.0 million in 2023, then plummeted by 51.79% to $81.0 million in 2024, then changed by 0.0% to $81.0 million in 2025.
  • Its last three reported values are $81.0 million in Q3 2025, $114.0 million for Q2 2025, and $90.0 million during Q1 2025.